Verastem, Inc. Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value
Verastem, Inc. (VSTM) had Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value of $21.16 million as of 2024-09-30, per its 10-Q filed 2024-11-06.
Financial Statements › Notes › Class of Stock Disclosures
us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue · last filed 2025-03-20
- 2024-09-30: Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value $21.16M.
- 2024-06-30: Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value $21.16M.
- 2023-12-31: Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value $21.16M.
| Period end | Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value |
|---|---|
| 2024-09-30 | $21.16M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $21.16M 10-Q · filed 2024-08-08 |
| 2023-12-31 | $21.16M 10-K · filed 2025-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |